Anti-SPP2B/ SPPL2B/ IMP-4 monoclonal antibody

Anti-SPP2B/ SPPL2B/ IMP-4 antibody for FACS & in-vivo assay

Target products collectionGo to SPPL2B/SPPL2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1703-Ab-1/ GM-Tg-hg-MP1703-Ab-2Anti-Human SPPL2B monoclonal antibodyHuman
GM-Tg-rg-MP1703-Ab-1/ GM-Tg-rg-MP1703-Ab-2Anti-Rat SPPL2B monoclonal antibodyRat
GM-Tg-mg-MP1703-Ab-1/ GM-Tg-mg-MP1703-Ab-2Anti-Mouse SPPL2B monoclonal antibodyMouse
GM-Tg-cynog-MP1703-Ab-1/ GM-Tg-cynog-MP1703-Ab-2Anti-Cynomolgus/ Rhesus macaque SPPL2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1703-Ab-1/ GM-Tg-felg-MP1703-Ab-2Anti-Feline SPPL2B monoclonal antibodyFeline
GM-Tg-cang-MP1703-Ab-1/ GM-Tg-cang-MP1703-Ab-2Anti-Canine SPPL2B monoclonal antibodyCanine
GM-Tg-bovg-MP1703-Ab-1/ GM-Tg-bovg-MP1703-Ab-2Anti-Bovine SPPL2B monoclonal antibodyBovine
GM-Tg-equg-MP1703-Ab-1/ GM-Tg-equg-MP1703-Ab-2Anti-Equine SPPL2B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1703-Ab-1/ GM-Tg-hg-MP1703-Ab-2; GM-Tg-rg-MP1703-Ab-1/ GM-Tg-rg-MP1703-Ab-2;
GM-Tg-mg-MP1703-Ab-1/ GM-Tg-mg-MP1703-Ab-2; GM-Tg-cynog-MP1703-Ab-1/ GM-Tg-cynog-MP1703-Ab-2;
GM-Tg-felg-MP1703-Ab-1/ GM-Tg-felg-MP1703-Ab-2; GM-Tg-cang-MP1703-Ab-1/ GM-Tg-cang-MP1703-Ab-2;
GM-Tg-bovg-MP1703-Ab-1/ GM-Tg-bovg-MP1703-Ab-2; GM-Tg-equg-MP1703-Ab-1/ GM-Tg-equg-MP1703-Ab-2
Products NameAnti-SPPL2B monoclonal antibody
Formatmab
Target NameSPPL2B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SPPL2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SPP2B/ SPPL2B/ IMP-4 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1703
    Target NameSPPL2B
    Gene ID56928,73218,362828,710493,485071,101081277,504285,100060546
    Gene Symbol and Synonyms3110056O03Rik,IMP-4,IMP4,PSH4,PSL1,RGD1308556,SPPL2B
    Uniprot AccessionQ8TCT7,Q5PQL3
    Uniprot Entry NameSPP2B_HUMAN,SPP2B_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000005206
    Target ClassificationN/A

    The target: SPPL2B, gene name: SPPL2B, also named as IMP-4, IMP4, PSH4, PSL1. This gene encodes a member of the GXGD family of aspartic proteases. The GXGD proteases are transmembrane proteins with two conserved catalytic motifs localized within the membrane-spanning regions. This enzyme localizes to endosomes, lysosomes, and the plasma membrane. It cleaves the transmembrane domain of tumor necrosis factor alpha to release the intracellular domain, which triggers cytokine expression in the innate and adaptive immunity pathways. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.